Recombinant Anti-CEA Neutralizing Antibody (V3S-0622-YC95) (CAT#: V3S-0622-YC95)

Send Inquiry
  • fig1

Datasheet

MSDS

COA

Summary
Property
Applications
Protocols
Target

Summary

Description This product is a chimeric antibody against carcinoembryonic antigen (CEA). The antibody can significantly inhibit the growth of the human large intestine cancer and can simultaneously decrease the serum CEA level in naked mice carrying tumors.
Clonality Monoclonal
Host Species Human
Target Species Human
Isotype IgG1

Property

Expression Species HEK293F or CHO
Conjugation None
Purity >95%, determined by SDS-PAGE and SEC-HPLC
Endotoxin <1 EU/mg
Purification Protein A affinity purified
Sterility 0.2 μM filtered
Formulation PBS, pH 7.4
Preservation No preservatives
Stabilizer No stabilizers
Storage Store at 4°C within a week. For longer storage, aliquot and store at -20°C.

Applications

Application ELISA; IF; WB; FuncS
Application Notes The antibody is recommended for detection of CEA by ELISA, IF (1/100-1/500), WB (1/1000-1/5000), FuncS assays.

Protocols

ELISA Enzyme-Linked Immunosorbent Assay Protocol
WB Western Blot Protocol
FC Flow Cytometry Protocol

Target

Target CEA
Alternative Name Carcinoembryonic antigen
Research Area Cancer Research
For research use only, not directly for clinical use.
banner banner
© 2024 Creative Biolabs. All Rights Reserved.
antibody
ISO 9001 Certified - Creative Biolabs Quality Management System.
Online Inquiry